Senior Manager
MBX Biosciences
Senior Manager
MBX Biosciences
Develops peptide-based therapies for endocrine diseases
Working with Us
MBX Biosciences is a clinical-stage biopharmaceutical company headquartered in Carmel, Indiana, with a secondary office in Burlington, MA. Our mission is to transform the lives of people impacted by endocrine and metabolic disorders through our novel precision peptides.
Leveraging our proprietary Precision Endocrine Peptides (PEPs)™ platform, we are pioneering technology designed to overcome key limitations of existing therapies and enhance efficacy, tolerability, safety and convenience. Our team is advancing a pipeline of novel candidates with clinically validated targets, established endpoints for regulatory approval, and strong market potential.
Our pipeline includes canvuparatide (MBX 2109) for the treatment of chronic hypoparathyroidism, currently preparing for Phase 3 development, and a growing obesity portfolio that includes MBX 4291 in Phase 1 development, MBX 5765, a next-generation amycretin prodrug designed for once-monthly-dosing, as well as MBX 6180, a GLP/GIP/GCGR triple agonist prodrug for once monthly dosing; all of which optimize our PEP platform.
If you’re passionate about advancing innovative treatments for patients and shaping the future of precision peptide therapeutics, this is your chance to make a real impact alongside a fast-paced, growing, mission-driven team. To learn more, visit our website mbxbio.com and follow us on LinkedIn.
What You’ll Do
The Senior Manager, Clinical Data Management (CDM), reporting to Director, Clinical Data Strategy and Management, will play a pivotal role in a dynamic, cross-functional clinical development team focused on advancing treatments for endocrine and metabolic disorders. This role will provide hands-on leadership on day-to-day data management activities across MBX portfolio to ensure high quality and inspection ready clinical databases and data from all sources, while serving as a key data management partner to Clinical Operations, Clinical Development, Biostatistics, Statistical Programming, Safety, Quality, Medical Writing, and external data vendors.
What You’ll Bring
EEO Statement:
MBX Biosciences is an Equal Opportunity Employer and is committed to treating all applicants fairly without discrimination. We welcome applications from all individuals, regardless of race, national origin, gender, age, physical characteristics, social origin, disability, union membership, religion, family status, pregnancy, sexual orientation, gender identity, gender expression or any unlawful criterion under applicable law.
Develops peptide-based therapies for endocrine diseases
MBX Biosciences discovers and develops peptide-based therapies for endocrine and metabolic diseases. Its work centers on the Precision Endocrine Peptide (PEP) platform, which helps create novel peptide drug candidates that target endocrine pathways. The company advances these candidates through clinical trials to establish safety and efficacy, seeking regulatory approval and potential partnerships for commercialization. MBX differentiates itself with a proprietary peptide platform focused on gap areas in endocrine/metabolic medicine, moving programs in a clinical-stage biopharmaceutical model that relies on capital from investors until products reach the market. Its goal is to bring approved therapies to patients with unmet medical needs in endocrine and metabolic disorders through partnerships or licensing with larger pharma players when appropriate.
Explore more opportunities at MBX Biosciences